Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Max India Ltd receives...

    Max India Ltd receives lukewarm response on day 1 of listing

    Written by Geeta Sharma Sharma Published On 2016-07-14T17:15:54+05:30  |  Updated On 14 July 2016 5:15 PM IST
    Max India Ltd receives lukewarm response on day 1 of listing

    New Delhi : Max India Ltd. one of the three new holding companies formed after the demerger of the erstwhile Max India Limited, started trading on the National Stock Exchange (NSE) as well as the Bombay Stock Exchange (BSE) today. This third company of the Max Group, listed its shares at Rs 180 on the National Stock Exchange and Rs 195 on the Bombay Stock Exchange. However, the stock received a lukewarm response for immediately after its listing on the first day , with the stock declining by 5 percent. The lower circuit limit hit an intraday low of Rs 171 on the NSE and Rs 185.25 on the BSE.


    Max India stock manages investments in high-potential Health and Allied services businesses.

    The new ‘Max India Limited’, which is the holding company of Max Healthcare, Max Bupa Health Insurance and Antara Senior Living, is the third company to start trading on the bourses after the demerger of the erstwhile Max India. Max Financial Services and Max Ventures and Industries have already started trading ex-demerger on 27th January and 22nd June, 2016 respectively.


    Max Healthcare and Max Bupa Health Insurance are joit ventures (JV) with global leaders, Life Healthcare (South Africa) and Bupa Finance Plc. (UK), respectively. These businesses have well-entrenched positions in their respective categories, and are recognized for their outstanding service standards. Max India owns and actively manages a 45.95% per cent stake in Max Healthcare, a 51% stake in Max Bupa Health Insurance and a 100% stake in Antara Senior Living.


    Since 2011, Max Healthcare’s revenues have grown at a CAGR of 26% and the company turned profitable in FY2016 reporting an EBITDA of Rs. 215 Cr. and a Profit after Tax of Rs. 10 Cr. In the past one year, the company has undertaken significant expansion efforts including two large acquisitions in the Delhi/NCR region. In May 2015, the company acquired a 78% stake in Pushpanjali Crosslay Hospital and in October 2015, Max Healthcare acquired a 51% stake in marquee South Delhi-based Saket City Hospital from Smart Health City Pte Ltd. The company plans to expand the Saket City Hospital facility by adding 900 beds over the next few years, thereby expanding its capacity to 1200 beds. Combined with Max Healthcare’s existing and contiguously located flagship facility (Max Super Specialty Hospital Saket), Max Healthcare will have a footprint of more than 2,000 beds in the heart of South Delhi.


    Max India’s second operating company, Max Bupa, has registered a cumulative average growth rate of 80% in its Gross Written Premium (GWP) since its inception in 2010. The company reported GWP of Rs. 476 Cr. in FY2016, growing 28% over the previous year. Max India’s JV partner Bupa, a leading international healthcare group, recently acquired an additional stake in Max Bupa, increasing their shareholding from 26% to 49%. Max Bupa also recently tied-up with Bank of Baroda for a bancassurance corporate agency agreement. Under this agreement, Max Bupa will now be able to offer its comprehensive health insurance offering to the diverse customer base of Bank of Baroda across the country. Max Bupa already has bancassurance arrangements and strategic alliances with leading institutions such as Standard Chartered Bank, Federal Bank, Ratnakar Bank, Muthoot Finance and Bajaj Finserv. One of the fastest growing players in the segment, Max Bupa is now the 9th largest private health insurer in the country, recently achieving a milestone of 1 million retail customers. The Company now serves as a trusted health insurance partner to more than 2 million customers, including rural customers covered under the Government’s Rashtriya Swasthya Bima Yojana (RSBY) scheme.


    Antara Senior Living, the third company under Max India, is pioneering the concept of ‘Ageing in Place’ for the elderly by developing Senior Living communities in India. Antara’s maiden community with over 200 apartments, situated near Dehradun, Uttarakhand will be functional by December 2016.


    Speaking on the occasion of listing of the company, Rahul Khosla, President, Max Group and Chairman, Max India said, “There is a tremendous growth opportunity in each of the three underlying businesses of Max India. With only about 5% penetration of health insurance and 1.3 hospital beds per 1000 people, both Healthcare and Health Insurance sectors have very low penetration and therefore huge headroom for growth. Senior living is a sunrise industry in which Antara Senior Living is a pioneer.”


    Mohit Talwar, Managing Director, Max India said, “The listing of the new Max India will lead to a more specific value discovery for our businesses in the Health & Allied space and will provide investors the choice to be associated exclusively with these hig

    Antara Senior LivingBajaj FinservBombay Stock ExchangeBSEChairman Max IndiaFederal BankManaging Director Max IndiaMax BupaMax HealthcareMax India Ltd.Mohit TalwarMuthoot FinanceNational Stock ExchangeNSEPresident Max GroupRahul KhoslaRashtriya Swasthya Bima YojanaRatnakar BankStandard Chartered Bank
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok